Cannabinoids as Novel Anti-Inflammatory Drugs

Cited by (557)

Items 101–200 of 557

1. The Anti-Inflammatory Effects of Cannabis sativa Extracts on LPS-Induced Cytokines Release in Human Macrophages
   Mariia Zaiachuk, Santosh V. Suryavanshi, Nazar Pryimak, Igor Kovalchuk, Olga Kovalchuk · 2023 · Molecules
2. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression
   Amira Kamil Mohammed, Hasan Alghetaa, Kathryn Miranda, Kiesha Maria Wilson, Narendra Prasad Singh, Guoshuai Cai, Nagireddy Putluri, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2020 · International Journal of Molecular Sciences
3. The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis
   Samuel Hammond, Simon Erridge, Nagina Mangal, Barbara Pacchetti, Mikael Hans Sodergren · 2021 · Cannabis and Cannabinoid Research
4. Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis
   Nicholas Dopkins, Kathryn Miranda, Kiesha Maria Wilson, Bryan Latrell Holloman, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2021 · Journal of Neuroimmune Pharmacology
5. Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes
   Vinay Kumar, Workineh Torben, Joshua A. Mansfield, Xavier A. Alvarez, Curtis Vande Stouwe, Jian Li, Siddappa N. Byrareddy, Peter J. Didier, Bapi Pahar, Patricia E. Molina et al. · 2019 · Frontiers in Immunology
6. Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation
   Myuri T. Ruthirakuhan, Nathan Herrmann, Ana C. Andreazza, Nicolaas Paul L.G. Verhoeff, Damien Gallagher, Sandra E. Black, Alex Kiss, Krista L. Lanctôt · 2019 · Journal of Geriatric Psychiatry and Neurology
7. The Current and Potential Application of Medicinal Cannabis Products in Dentistry
   Henry I. C. Lowe, Ngeh J. Toyang, Blair Steele, Joseph Bryant, Wilfred F. Ngwa, Kaveh Nedamat · 2021 · Dentistry Journal
8. Challenges to develop novel anti‐inflammatory and analgesic drugs
   Bálint Botz, Kata Bölcskei, Zsuzsanna Helyes · 2016 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
9. Asthma associated with the use of cocaine, heroin, and marijuana: A review of the evidence
   Timothy H. Self, Samarth P. Shah, Katherine L. March, Christopher W. Sands · 2016 · Journal of Asthma
10. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers
    Silvia Lorenia Cruz, Elizabeth Sánchez-Miranda, Jorge Iván Castillo-Arellano, Rodolfo Daniel Cervantes‐Villagrana, Alfredo Ibarra-Sánchez, Claudia González‐Espinosa · 2018 · International Immunopharmacology
11. Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats
    César Angel Ossola, Pablo Nicolás Surkin, Antonela Pugnaloni, Claudia Ester Mohn, Juan Carlos Elverdin, Javier Fernández‐Solari · 2012 · Inflammation Research
12. Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study
    Kheskanya Kongkadee, Wudtichai Wisuitiprot, Kornkanok Ingkaninan, Neti Waranuch · 2022 · Archives of Oral Biology
13. Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells
    Ana Juknat, Ewa Kozela, Nathali Kaushansky, Raphael Mechoulam, Zvi Vogel · 2015 · Journal of Basic and Clinical Physiology and Pharmacology
14. Antiinflammatory Potential of Medicinal Plants: A Source for Therapeutic Secondary Metabolites
    Nirit Bernstein, Muhammad Akram, Muhammad Daniyal, Hinanit Koltai, Marcelo Fridlender, Jonathan Gorelick · 2018 · Advances in agronomy
15. Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation
    Eleonora Patsenker, Philip Sachse, Andrea Chicca, Maria Salomé Gachet, Vreni Schneider, Johan Mattsson, Christian Lanz, Mathias Worni, Andrea De Gottardi, Mariam Semmo et al. · 2015 · International Journal of Molecular Sciences
16. Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells
    Jessica Margaret Sido, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2015 · Journal of Leukocyte Biology
17. Therapy implications of the role of interleukin-2 in cancer
    Paolo Lissoni · 2016 · Expert Review of Clinical Immunology
18. Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish (Danio rerio)
    Zacharias Pandelides, Cammi Thornton, Anika S. Faruque, Alyssa P. Whitehead, Kristine L. Willett, Nicole M. Ashpole · 2020 · GeroScience
19. Comprehending and improving cannabis specialized metabolism in the systems biology era
    Paco Romero, Arnau Peris-Cuesta, Karina Vergara, José Tomás Matus · 2020 · Plant Science
20. Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
    Md Sultan Mahmud, Mohammad Sorowar Hossain, A T M Faiz Ahmed, Md Zahidul Islam, Md Emdad Sarker, Md Reajul Islam · 2021 · Molecules
21. Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
    Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, Mădălina Larion, Walther Bild, Gabriela Dumitriţa Stanciu, Carmen Solcan, Veronica Bild · 2022 · Biology
22. 2-Arachidonoylglycerol ameliorates inflammatory stress-induced insulin resistance in cardiomyocytes
    Dipanjan Chanda, Yvonne Oligschlaeger, Ilvy M. E. Geraets, Yilin Liu, Xiaoqing Zhu, Jieyi Li, Miranda Nabben, Will A. Coumans, Joost J.F.P. Luiken, Jan F. C. Glatz et al. · 2017 · Journal of Biological Chemistry
23. Discovery of APD371: Identification of a Highly Potent and Selective CB2Agonist for the Treatment of Chronic Pain
    Sangdon Han, Lars H. Thoresen, Jae‐Kyu Jung, Xiuwen Zhu, Jayant Thatte, Michelle Solomon, Ibragim Gaidarov, David J. Unett, Woo Hyun Yoon, Jeremy Barden et al. · 2017 · ACS Medicinal Chemistry Letters
24. The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways
    Muthanna Ali Sultan, Hasan Alghetaa, Amira Kamil Mohammed, Osama Azeldeen Abdulla, Paul J. Wisniewski, Narendra Prasad Singh, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2021 · Frontiers in Pharmacology
25. Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices
    Roberta Ottria, Alessandro Ravelli, Fausto Gigli, Pierangela Ciuffreda · 2014 · Journal of Chromatography B
26. Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPARγ
    Fernanda da Silva Rodrigues, William Robert Newton, Isadora D’Ávila Tassinari, Felipe Henrique da Cunha Xavier, Adél Marx, Luciano Stürmer de Fraga, Karen L. Wright, Renata Padilha Guedes, Victorio Bambini-Júnior · 2024 · Neurochemistry International
27. For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
    Rebecca J. Henry, Daniel M. Kerr, David P. Finn, Michelle Roche · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
28. Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury
    Rodrigo Zon Soares, Francieli Silva Vuolo, Dhébora Mozena Dall’Igna, Monique Michels, José Alexandre S. Crippa, Jaime E. C. Hallak, Antônio Waldo Zuardi, Felipe Dal‐Pizzol · 2015 · Revista Brasileira de Terapia Intensiva
29. New vistas on cannabis use disorder
    Miriam Melis, Roberto Frau, Peter W. Kalivas, Sade M. Spencer, Vivian C. Chioma, Erica Zamberletti, Tiziana Rubino, Daniela Parolaro · 2017 · Neuropharmacology
30. Assessment of spent hemp biomass as a potential ingredient in ruminant diet: nutritional quality and effect on performance, meat and carcass quality, and hematological parameters in finishing lambs
    Nathan B. Parker, Massimo Bionaz, Hunter R. Ford, Agung Irawan, Erminio Trevisi, Serkan Ateş · 2022 · Journal of Animal Science
31. Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases
    Bahareh Abd‐Nikfarjam, Amirhossein Dolati‐Somarin, Vafa Baradaran Rahimi, Vahid Reza Askari · 2023 · BioFactors
32. Targeting Cannabinoid Receptors as a Novel Approach in the Treatment of Graft-versus-Host Disease: Evidence from an Experimental Murine Model
    Rupal Pandey, Venkatesh L. Hegde, Mitzi Nagarkatti, Prakash S. Nagarkatti · 2011 · Journal of Pharmacology and Experimental Therapeutics
33. Cannabinoids and the Microbiota–Gut–Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders
    Hollis C. Karoly, Raeghan L. Mueller, L. Cinnamon Bidwell, Kent E. Hutchison · 2019 · Alcoholism Clinical and Experimental Research
34. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story
    Emilia Carbone, Antonia Manduca, Claudia Cacchione, Stefano Vicari, Viviana Trezza · 2020 · Neuroscience & Biobehavioral Reviews
35. FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus
    Rebecca J. Henry, Daniel M. Kerr, David P. Finn, Michelle Roche · 2014 · Journal of Neuroimmunology
36. Molecular dynamics of inflammation resolution: therapeutic implications
    Amro Mohamed Soliman, Mohamed M. Soliman, Syed Sajid Hussain Shah, Habeeb Ali Baig, Nawal Salama Gouda, Bandar Theyab Alenezi, Awwad K. Alenezy, Ahmed M. S. Hegazy, Muhammad Jan, Elhassan Hussein Eltom Abdalla · 2025 · Frontiers in Cell and Developmental Biology
37. Cannabinoid signaling promotes the de‐differentiation and proliferation of Müller glia‐derived progenitor cells
    Warren A. Campbell, S A Blum, Alana Reske, Thanh V. Hoang, Seth Blackshaw, Andy J. Fischer · 2021 · Glia
38. “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
    Mona Khoury, Idan Cohen, Gil Bar‐Sela · 2022 · Pharmaceutics
39. Mitofusin 2 confers the suppression of microglial activation by cannabidiol: Insights from in vitro and in vivo models
    Mengfan Li, Bingtian Xu, Xing Li, Yueqi Li, Shuqin Qiu, Kechun Chen, Zhuhe Liu, Yuewen Ding, Honghao Wang, Jiangping Xu et al. · 2022 · Brain Behavior and Immunity
40. The molecular connections between the cannabinoid system and endometriosis
    Ana Maria Sanchez, Paola Viganò, Alessandra Mugione, Paola Panina‐Bordignon, Massimo Candiani · 2012 · Molecular Human Reproduction
41. Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation
    Ravi Kumar Murumalla, Karima Bencharif, Lydie Gence, Amritendu Bhattacharya, Frank Tallet, Marie‐Paule Gonthier, Stefania Petrosino, Vincenzo Di Marzo, Maya Césari, Laurence Hoareau et al. · 2011 · Journal of Inflammation
42. Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
    Tomasz Charytoniuk, Hubert Żywno, Karolina Konstantynowicz-Nowicka, Klaudia Berk, Wiktor Bzdęga, Adrian Chabowski · 2020 · International Journal of Molecular Sciences
43. RETRACTED: Cannabinoids as anti-ROS in aged pancreatic islet cells
    Maryam Baeeri, Mahban Rahimifard, Seyed Mojtaba Daghighi, Fazlullah Khan, Seyed Alireza Salami, Shermineh Moeini‐Nodeh, Hamed Haghi‐Aminjan, Zahra Bayrami, Farhad Rezaee, Mohammad Reza Abdollahi · 2020 · Life Sciences · Retracted
44. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination
    Victor Longoria, Hannah Parcel, Bameelia Toma, Annu Minhas, Rana R. Zeine · 2022 · Biomedicines
45. Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells
    Vladimir N. Ivanov, Jinhua Wu, Tony J. C. Wang, Tom K. Hei · 2019 · Oncotarget
46. Immune Dysregulation in Depression and Anxiety: A Review of the Immune Response in Disease and Treatment
    Christopher Hole, Akash Dhamsania, Cassandra Brown, Rebecca Jean Ryznar · 2025 · Cells
47. Cannabidiol (CBD): Perspectives from Pinterest
    Julie Williams Merten, Benjamin Thomas Gordon, Jessica L. King, Calista Pappas · 2020 · Substance Use & Misuse
48. HU ‐446 and HU ‐465, Derivatives of the Non‐psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells
    Ewa Kozela, Christeene G. Haj, Lumir Hanuš, Mukesh Chourasia, Avital Shurki, Ana Juknat, Nathali Kaushansky, Raphael Mechoulam, Zvi Vogel · 2015 · Chemical Biology & Drug Design
49. Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor
    Lewis Taylor, Ivy Christou, Theodore S. Kapellos, Alice Buchan, Maximillian Hugo Brodermann, Matteo Gianella-Borradori, Angela J. Russell, Asif Jilani Iqbal, David R. Greaves · 2015 · Scientific Reports
50. RNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation
    Xiaoming Yang, Marpe Bam, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2016 · Journal of Biological Chemistry
51. Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis
    Xiaoming Yang, Marpe Bam, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2019 · Scientific Reports
52. Epigenome‐wide analysis uncovers a blood‐based DNA methylation biomarker of lifetime cannabis use
    Markunas, Christina A., Hancock, Dana B., Xu, Zongli, Quach, Bryan C., Fang, Fang, Sandler, Dale P., Johnson, Eric O., Taylor, Jack A. · 2021 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
53. Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation
    Newman Osafo, Kofi Oduro Yeboah, Aaron Opoku Antwi · 2021 · Molecular Biology Reports
54. THC and CBD Fingerprinting of an Elite Cannabis Collection from Iran: Quantifying Diversity to Underpin Future Cannabis Breeding
    Mahboubeh Mostafaei Dehnavi, Ali Ebadi, Afshin Peirovi, Gail Taylor, Seyed Alireza Salami · 2022 · Plants
55. Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation
    Michael D. Roth, Julie T. Castaneda, Sylvia M. Kiertscher · 2015 · Journal of Neuroimmune Pharmacology
56. The impact of E-cigarette vaping and vapour constituents on bone health
    Thomas A. Nicholson, Aaron Scott, Matthew Newton Ede, Simon Wyn Jones · 2021 · Journal of Inflammation
57. Adverse Impact of Cannabis on Human Health
    Mark Chandy, Masataka Nishiga, Tzu-Tang Wei, Naomi M. Hamburg, Kari Christine Nadeau, Joseph C. Wu · 2023 · Annual Review of Medicine
58. Administration of Δ9‐Tetrahydrocannabinol (THC) Post‐Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity
    Amira Kamil Mohammed, Hasan Alghetaa, Muthanna Ali Sultan, Narendra Prasad Singh, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2020 · Frontiers in Pharmacology
59. Cannabis sativa: an overview
    Gary Richter, Trina Hazzah, Joshua A. Hartsel, Joshua Eades, Brian Hickory, Alexandros Makriyannis · 2021 · Elsevier eBooks
60. Cannabis and Inflammation in HIV: A Review of Human and Animal Studies
    Ronald J. Ellis, Natalie Wilson, Scott N. Peterson · 2021 · Viruses
61. Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections
    Qiongqiong Angela Zhou, Junko Kato-Weinstein, Yingzhu Li, Yi Deng, Roger Granet, Linda V. Garner, Cynthia Liu, Dmitrii A. Polshakov, Chris Gessner, Steven Watkins · 2020 · ACS Pharmacology & Translational Science
62. The immunosuppressive effect of the endocannabinoid system on the inflammatory phenotypes of macrophages and mesenchymal stromal cells: a comparative study
    Tim Ruhl, Corina Corsten, Justus P. Beier, Bong‐Sung Kim · 2020 · Pharmacological Reports
63. Does inflammation link stress to poor COVID‐19 outcome?
    Steven J. Lamontagne, Diego A. Pizzagalli, Mary C. Olmstead · 2020 · Stress and Health
64. Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease
    Deepthi Rapaka, Veera Raghavulu Bitra, Siva Reddy Challa, Paul Chukwuemeka Adiukwu · 2021 · Neuropeptides
65. TNFα in MS and Its Animal Models: Implications for Chronic Pain in the Disease
    Aislinn D. Maguire, John R. Bethea, Bradley J. Kerr · 2021 · Frontiers in Neurology
66. Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch
    Jonas Kleyer, Simon Nicolussi, Peter Taylor, Deborah Simonelli, Evelyne Furger, Pascale Anderle, Jürg Gertsch · 2012 · Biochemical Pharmacology
67. Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells
    Tim Ruhl, Bong‐Sung Kim, Justus P. Beier · 2018 · Experimental Cell Research
68. Proposed Canadian Consensus Guidelines on Osteoarthritis Treatment Based on OA-COAST Stages 1–4
    Conny Mosley, Tara Edwards, Laura Romano, Geoffrey Truchetti, Laurie Dunbar, Teresa Schiller, Tom Gibson, Charles Bruce, Éric Troncy · 2022 · Frontiers in Veterinary Science
69. Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
    Xiuyuan Zhang, Shan Gao, Jinfeng Niu, Li Pan, Juan Deng, Shixin Xu, Zhihong Wang, Weiwei Wang, Deling Kong, Chen Li · 2016 · Cellular Physiology and Biochemistry
70. Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase
    Haley A. Vecchiarelli, Maria Morena, Catherine M. Keenan, Vincent Chiang, Kaitlyn Tan, Min Qiao, Kira D. Leitl, Alessia Santori, Quentin J. Pittman, Keith A. Sharkey et al. · 2021 · Neuropsychopharmacology
71. Cannabis Use and Markers of Systemic Inflammation: The Coronary Artery Risk Development in Young Adults Study
    Omayma Alshaarawy, Stephen S Sidney, Reto Auer, David Green, Elsayed Z. Soliman, David Calvin Goff, James Christopher Anthony · 2019 · The American Journal of Medicine
72. Changes in Lipid Profile of Keratinocytes from Rat Skin Exposed to Chronic UVA or UVB Radiation and Topical Application of Cannabidiol
    Wojciech Łuczaj, M. Rosário Domingues, Pedro M. Domingues, Elźbieta Skrzydlewska · 2020 · Antioxidants
73. GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration
    Douglas J. Hermes, Barkha J. Yadav-Samudrala, Changqing Xu, Jacqueline E. Paniccia, Rick B. Meeker, Michael Armstrong, Nichole A. Reisdorph, Benjamin F. Cravatt, Ken Mackie, Aron H. Lichtman et al. · 2021 · Experimental Neurology
74. Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription
    Catherine DeMarino, Maria Cowen, Pooja Khatkar, Bianca Cotto, Heather Branscome, Yuriy Kim, Sarah Al Sharif, Emmanuel T. Agbottah, Weidong Zhou, Cecilia Theresa Costiniuk et al. · 2022 · Cells
75. Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1
    Austin R. Jackson, Venkatesh L. Hegde, Prakash S. Nagarkatti, Mitzi Nagarkatti · 2013 · Journal of Leukocyte Biology
76. Sensitivity of the Fasciae to the Endocannabinoid System: Production of Hyaluronan-Rich Vesicles and Potential Peripheral Effects of Cannabinoids in Fascial Tissue
    Caterina Fede, Carmelo Pirri, Lucía Petrelli, Diego Guidolin, Chenglei Fan, Raffaele De, Carla Stecco · 2020 · International Journal of Molecular Sciences
77. Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?
    Courtney Griffiths, James Aikins, David Philip Warshal, Olga Ostrovsky · 2021 · Biomolecules
78. Exploring the therapeutic potential of cannabinoids in cancer by modulating signaling pathways and addressing clinical challenges
    Manal Bint Faiz, Faiza Naeem, Muhammad Irfan, Muhammad Adeel Aslam, Letı́cia M. Estevinho, Dilek Arslan Ateşşahin, Asma M. Alshahrani, Daniela Cornelia Călina, Khushbukhat Khan, Javad Sharifi‐Rad · 2024 · Discover Oncology
79. Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis?
    Inês Correia‐Sá, Anita Paiva, Cláudia Carvalho, Maria Augusta Vieira‐Coelho · 2020 · Pharmacological Research
80. Cannabinoids in the Management of Musculoskeletal Pain
    Kim Madden, Niek van der Hoek, Simrun Chona, Annie George, Tristiana Dalchand, Hassan Baldawi, George Mammen, Mohit Bhandari · 2018 · JBJS Reviews
81. Cancer cachexia: a multifactoral disease that needs a multimodal approach
    Renee Stubbins, Eric Bernicker, Eamonn M.M. Quigley · 2019 · Current Opinion in Gastroenterology
82. Periodontal Conditions and Whole Salivary IL-17A and -23 Levels among Young Adult Cannabis sativa (Marijuana)-Smokers, Heavy Cigarette-Smokers and Non-Smokers
    Fawad Javed, Abeer Sami Al-Zawawi, Khaled S. Allemailem, Ahmad Almatroudi, Abid Mehmood, Darshan Devang Divakar, Abdulaziz Abdullah Al Kheraif · 2020 · International Journal of Environmental Research and Public Health
83. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review
    Ashwini Patil, Umesh B. Mahajan, Yogeeta O. Agrawal, Kalpesh Ramdas Patil, Chandragouda Raosaheb Patil, Shreesh Kumar Ojha, Charu Sharma, Sameer N. Goyal · 2020 · Biomedicine & Pharmacotherapy
84. Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer’s disease
    Magdalena Leszko, Senthil Raj Meenrajan · 2021 · Complementary Therapies in Medicine
85. Hierarchical control systems for the regulation of physiological homeostasis and affect: Can their interactions modulate mood and anhedonia?
    Otto Muzik, Vaibhav A. Diwadkar · 2019 · Neuroscience & Biobehavioral Reviews
86. In quest of a new therapeutic approach in COVID-19: the endocannabinoid system
    Ondine Patricia LUCACIU, Ovidiu Aghiorghiesei, Nausica Bianca Petrescu, Ioana Codruța Mirică, Horea Rares Ciprian Benea, Dragoș Apostu · 2021 · Drug Metabolism Reviews
87. Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study
    Nicholas H. B. Schräder, Emily S. Gorell, Roy E. Stewart, José C. Duipmans, Nicole Harris, Victoria Aurora Ferrer Pérez, Jean Yuh Tang, André Paul Wolff, Maria C. Bolling · 2021 · Orphanet Journal of Rare Diseases
88. Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy
    Mariia Zaiachuk, Nazar Pryimak, Olga Kovalchuk, Igor Kovalchuk · 2021 · Frontiers in Medicine
89. The Potential Use of Cannabis in Tissue Fibrosis
    Nazar Pryimak, Mariia Zaiachuk, Olga Kovalchuk, Igor Kovalchuk · 2021 · Frontiers in Cell and Developmental Biology
90. New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts
    Bo Wang, Dongping Li, Anna Fiselier, Igor Kovalchuk, Olga Kovalchuk · 2022 · Cell Death Discovery
91. The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice
    Takayo Haruna, Masahiko Soga, Yasuhide Morioka, Kinichi Imura, Yoko Furue, Mina Yamamoto, Jun Hayakawa, Masashi Deguchi, Akinori Arimura, Kiyoshi Yasui · 2017 · Pharmacology
92. Thirty years of translational research in Mobility Medicine: Collection of abstracts of the 2020 Padua Muscle Days
    Ugo Carraro · 2020 · European Journal of Translational Myology
93. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis
    Hina Khan, Fareeha Khalid Ghori, Uzma Ghani, Aneela Javed, Saadia Zahid · 2022 · Molecular Biology Reports
94. Anti‐inflammatory effects of cannabidiol against lipopolysaccharides in cardiac sodium channels
    Mohamed A. Fouda, Yasmine Fathy Mohamed, Rachel C. Fernandez, Peter C. Ruben · 2022 · British Journal of Pharmacology
95. The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry
    Nishaanth Dalavaye, Simon Erridge, Martha Nicholas, Manaswini Pillai, Lara Bapir, Carl Holvey, Ross Coomber, James Rucker, Jonathan M. Hoare, Mikael Hans Sodergren · 2022 · Expert Review of Gastroenterology & Hepatology
96. The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis
    Jessica Freundt-Revilla, Franciska Heinrich, Alexander A. Zoerner, Felix Kaspar Gesell, Martin Beyerbach, Merav Hagar Shamir, Anna Oevermann, Wolfgang Baumgärtner, Andrea Tipold · 2018 · PLoS ONE
97. Hydroxytyrosol Inhibits Cannabinoid CB1 Receptor Gene Expression in 3T3‐L1 Preadipocyte Cell Line
    Valeria Tutino, Antonella Orlando, Francesco Russo, Maria Notarnicola · 2015 · Journal of Cellular Physiology
98. Immunosuppressive activity of non-psychoactive Cannabis sativa L. extract on the function of human T lymphocytes
    Seema Devi, Amy Marisa Zimmermann-Klemd, Bernd L. Fiebich, Michael Heinrich, Carsten Gründemann, Peter Steinberger, Stefanie Kowarschik, Roman Huber · 2022 · International Immunopharmacology
99. Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects
    Alireza Tahamtan, Shahrzad Rezaiy, Saeed Samadizadeh, Abdolvahab Moradi, Alijan Tabarraei, Naeme Javid, Morteza Oladnabi, Mohammad Hosein Naeimi · 2019 · Journal of Molecular Neuroscience
100. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors
     Michael S. Malamas, Shrouq I. Farah, Manjunath Lamani, Dimitrios N. Pelekoudas, Nicholas Thomas Perry, Girija Rajarshi, Christina Yume Miyabe, Chandrashekhar Honrao, Jay M. West, Spiro Pavlopoulos et al. · 2019 · Bioorganic & Medicinal Chemistry